Lin BioScience, Inc. (TPEX:6696)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
389.00
-10.50 (-2.63%)
Mar 9, 2026, 2:00 PM CST

Lin BioScience Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
32.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pell Bio-Med Technology 29.99M
Lumosa Therapeutics 35.83M
Oneness Biotech 117.33M
Polaris Group 70.83M
Sunmax Biotechnology 2.00B
EirGenix 936.18M
TaiMed Biologics 607.22M
AP Biosciences 32.25M
Revenue Rankings